Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Dec;29(7):777-822.
doi: 10.1210/er.2008-0024. Epub 2008 Oct 29.

The metabolic syndrome

Marc-Andre Cornier  1 , Dana Dabelea, Teri L Hernandez, Rachel C Lindstrom, Amy J Steig, Nicole R Stob, Rachael E Van Pelt, Hong Wang, Robert H Eckel
Affiliations
Review

The metabolic syndrome

Marc-Andre Cornier et al. Endocr Rev. 2008 Dec.

Abstract

The "metabolic syndrome" (MetS) is a clustering of components that reflect overnutrition, sedentary lifestyles, and resultant excess adiposity. The MetS includes the clustering of abdominal obesity, insulin resistance, dyslipidemia, and elevated blood pressure and is associated with other comorbidities including the prothrombotic state, proinflammatory state, nonalcoholic fatty liver disease, and reproductive disorders. Because the MetS is a cluster of different conditions, and not a single disease, the development of multiple concurrent definitions has resulted. The prevalence of the MetS is increasing to epidemic proportions not only in the United States and the remainder of the urbanized world but also in developing nations. Most studies show that the MetS is associated with an approximate doubling of cardiovascular disease risk and a 5-fold increased risk for incident type 2 diabetes mellitus. Although it is unclear whether there is a unifying pathophysiological mechanism resulting in the MetS, abdominal adiposity and insulin resistance appear to be central to the MetS and its individual components. Lifestyle modification and weight loss should, therefore, be at the core of treating or preventing the MetS and its components. In addition, there is a general consensus that other cardiac risk factors should be aggressively managed in individuals with the MetS. Finally, in 2008 the MetS is an evolving concept that continues to be data driven and evidence based with revisions forthcoming.

PubMed Disclaimer

Figures

F<sc>ig</sc>. 1.
Fig. 1.
Prevalence of the MetS across age groups and gender in various countries. The MetS prevalence continues to increase with age into the sixth decade, with prevalence in women catching up to and then exceeding that in men after the age of 60 yr in the United States and across the globe (27 28 44 55 65 ).
F<sc>ig</sc>. 2.
Fig. 2.
The prevalence of the MetS among adolescents. Prevalence of the MetS among U.S. adolescents (age 12–19 yr) increased from 4.2% in NHANES III (1988–1992) to 6.4% in NHANES 1999–2000 (P < 0.001) in both sexes and in all three major race/ethnic groups analyzed (62 ).
F<sc>ig</sc>. 3.
Fig. 3.
Pathophysiology of the Metabolic Syndrome and insulin resistance. A, FFA are released in abundance from an expanded adipose tissue mass. In the liver, FFA result in increased production of glucose and triglycerides and secretion of VLDL. Associated lipid/lipoprotein abnormalities include reductions in HDL-C and increased density of LDL. FFA also reduce insulin sensitivity in muscle by inhibiting insulin-mediated glucose uptake. Associated defects include a reduction in glucose partitioning to glycogen and increased lipid accumulation. Elevated circulating glucose and to some extent FFA increase pancreatic insulin secretion, resulting in hyperinsulinemia. Hyperinsulinemia may result in enhanced sodium reabsorption and increased sympathetic nervous system activity and may contribute to hypertension, as might increased levels of FFA. B, Superimposed and contributory to the insulin resistance produced by excessive FFA is the paracrine and endocrine effect of the proinflammatory state. Produced by a variety of cells in adipose tissue, including adipocytes and monocyte-derived macrophages, the enhanced secretion of IL-6 and TNF-α among others results in more insulin resistance and lipolysis of adipose tissue triglyceride stores, resulting in increased circulating FFA. IL-6 and other cytokines also are increased in the circulation and may enhance hepatic glucose production, the production of VLDL by the liver, and insulin resistance in muscle. Cytokines and FFA also increase the production of fibrinogen and PAI-1 by the liver, complementing the overproduction of PAI-1 by adipose tissue. This results in a prothrombotic state. Reductions in the production of the antiinflammatory and insulin-sensitizing cytokine adiponectin are also associated with the metabolic syndrome and insulin resistance. [Reproduced from R.H. Eckel et al.: Lancet 365:1415–1428, 2005 (113 ) with permission from Elsevier.]
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497 - PubMed
    1. Sarafidis PA, Nilsson PM 2006. The metabolic syndrome: a glance at its history. J Hypertens 24:621–626 - PubMed
    1. Kylin ES 1923. Hypertonie-Hyperglykamie-Hyperurikamiesyndrome. Zentralblatt fur innere Medizin 44
    1. Vague J 1947. La differenciation sexuelle, facteur determinant des formes de l’obesite. Presse Med 30 339–340 - PubMed
    1. Despres JP 1993. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9:452–459 - PubMed
-